You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 7, August 15, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (38)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Academic Medical Centers
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Status of Clinical Research in Academic Health Centers

Views From the Research Leadership

Eric G. Campbell, PhD; Joel S. Weissman, PhD; Ernest Moy, MD, MPH; David Blumenthal, MD, MPP

JAMA. 2001;286:800-806.

Context  The changing state of the health care system in the United States may be adversely affecting clinical research conducted in academic health centers (AHCs). Few formal data have been gathered about the nature and extent of the problems facing clinical research or the effects of remedies undertaken by AHCs.

Objectives  To assess the perceived quality and health of the clinical research enterprise and to determine challenges and adaptations to current environmental pressures.

Design, Setting, and Participants  Mailed survey conducted between December 1998 and March 1999 of a subsample of department chairs and senior research administrators (SRAs) in all US medical schools. Of the 712 potential respondents, 478 completed a questionnaire, yielding an overall response rate of 67.1% (64.8% for SRAs and 67.8% for department chairs).

Main Outcome Measures  Ratings of overall health/robustness of clinical research, quality of research in 5 domains, extent of challenges to performing research, and sense of urgency in responding to research challenges; formal strategies for research-related tasks and their effects.

Results  Slightly more than half (52%) of all respondents rated the health of the clinical research enterprise as good or excellent compared with 63% for nonclinical research (P<.001). Respondents were most likely to rate nonclinical research as high in quality (79%) compared with 70% for phase 3 clinical trials, 67% for translational research, 65% for phase 1 and 2 trials, and 57% for health services research (for all comparisons with nonclinical research, P<.001). Pressure on clinical faculty to see patients was perceived as a moderate-to-large problem for clinical research by the largest percentage of respondents (93%), followed by insufficient clinical revenues (89%), recruiting trained researchers (75%), lack of external support for clinical research (72%), competition from contract research organizations (48%), problems introduced by the institutional review board process (38%), and finding research participants (37%). In total, 81% of respondents considered the challenges facing clinical research in AHCs to be urgent or extremely urgent.

Conclusions  Academic leaders perceive clinical research activities in AHCs to be less healthy, of poorer quality, and facing greater challenges than nonclinical research activities. Many AHCs do not have policies or mechanisms to address challenges facing the clinical research mission. Even among those with such policies, more than half do not believe these policies have had large positive effects. Our findings support the view that the clinical research workforce and infrastructure may need to be expanded and strengthened to keep pace with advances in basic research.


Author Affiliations: The Institute for Health Policy, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School (Drs Blumenthal, Campbell, and Weissman) and Department of Health Care Policy (Drs Blumenthal and Weissman), Boston, Mass; and Association of American Medical Colleges, Washington, DC (Dr Moy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Clinical Investigators— The Endangered Species Revisited
Edward D. Miller
JAMA. 2001;286(7):845-846.
EXTRACT | FULL TEXT  

August 15, 2001
JAMA. 2001;286(7):863-864.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Involving medical students in research
Metcalfe
JRSM 2008;101:102-103.
FULL TEXT  

Development and Interim Results of a Clinical Research Training Fellowship
Gordon and Dionne
J Dent Educ 2007;71:1040-1047.
ABSTRACT | FULL TEXT  

Effect of a Clinical Trial Alert System on Physician Participation in Trial Recruitment
Embi et al.
Arch Intern Med 2005;165:2272-2277.
ABSTRACT | FULL TEXT  

The Contract Research Organization and the Commercialization of Scientific Research
Mirowski and Van Horn
Social Studies of Science 2005;35:503-548.
ABSTRACT  

The commercialization of clinical research: who pays the piper, calls the tune?
Freemantle and Stocken
Fam Pract 2004;21:335-336.
FULL TEXT  

The state of patient-oriented research in neurology
Sacco et al.
Neurology 2004;62:1051-1055.
FULL TEXT  

NIH Peer Review of Grant Applications for Clinical Research
Kotchen et al.
JAMA 2004;291:836-843.
ABSTRACT | FULL TEXT  

The Clinical Researcher--An "Emerging" Species
Snyderman
JAMA 2004;291:882-883.
FULL TEXT  

Clinical Research and the NIH -- A Report Card
Nathan and Wilson
NEJM 2003;349:1860-1865.
FULL TEXT  

Central Challenges Facing the National Clinical Research Enterprise
Sung et al.
JAMA 2003;289:1278-1287.
ABSTRACT | FULL TEXT  

Research Training in the Czech Republic
Balon and Hoschl
Acad. Psychiatry 2002;26:125-127.
FULL TEXT  

Clinical Investigators-- The Endangered Species Revisited
Miller
JAMA 2001;286:845-846.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.